Telehealth Treatment for Opioid Use Disorders
Opioid Use Disorder
About this trial
This is an interventional treatment trial for Opioid Use Disorder focused on measuring Harm Reduction, Medication for Opioid Use Disorder
Eligibility Criteria
Inclusion Criteria: Can speak, read and write in English Provision of signed and dated informed consent form Have a history of at least one opioid overdose Screened positive for OUD, moderate or severe, based on the Diagnostic and Statistical Manual-5th Edition Have a working cell phone number and working device that can access a web browser and receive texts (i.e., smartphone, tablet or computer) OR be willing to use a device provided by the study team Can provide a working email address OR be willing to create one Exclusion Criteria: Current use of buprenorphine, methadone, or naltrexone for a substance use disorder Pregnancy or lactation Known current suicide risk based on participant self-report On parole or incarcerated at time of enrollment based on participant self-report
Sites / Locations
Arms of the Study
Arm 1
Experimental
OUD Telehealth Platform
Participants will be assigned to receive the OUD Telehealth Platform, which will be delivered remotely by research staff.